Submission of new drug information

First Coast appreciates your efforts to provide us with information regarding new drugs, new or revised indications, or marketing materials for forthcoming drugs or medical devices. Specifically, we are looking for the wholesale acquisition cost (WAC), average wholesale price (AWP), national drug code (NDC) number, indications for use, and details about any off-label uses.

Please forward the information described above to: medicalaffairs@guidewellsource.com

It is not necessary to submit your information to multiple people at First Coast. Information submitted to medical affairs will be kept on file and disseminated accordingly.

Once received, the information will be forwarded to the appropriate staff for reference in the event future claims are submitted. Submission of your information does not guarantee coverage by First Coast. Section 1862(a)(1)(A) of the SSA (Social Security Act), reasonable and necessary guidelines, applies to all services reported to Medicare.

We will contact you if we have any questions regarding your submitted information. 

Open meetings held by First Coast are not a forum for the discussion or submission of new drugs, new or revised indications, or marketing of forthcoming drugs or medical devices. Information regarding new drugs, indications, or marketing information should be submitted as indicated above. The open meeting is designated for the presentation of information related to proposed LCDs only.

Note: HIPAA regulations prevent us from discussing providers’ claims with a third party. Providers should contact our customer service with any questions regarding claim denials, pricing and/or billing. If a provider feels a claim paid incorrectly or denied in error, they have the right to request an appeal. Please visit our appeals center for more detail on how to file an appeal.